Pharmaceutical

Cure Genetics and Frametact seek gene cures for neurological ailments

Cure Genetics has entered a partnership and licensing deal with Frametact to develop gene therapy for familial neurological ailments.

Sep 15, 2023 - 20:00
Cure Genetics and Frametact seek gene cures for neurological ailments
Cure Genetics has entered a partnership and licensing deal with Frametact to develop gene therapy for familial neurological ailments.
Read the original article

Tags:

Previous Article

Signal: Danaher’s $5.7bn acquisition of Abcam faces stand-off with founder

Next Article

Market cap rebound by top 20 biopharmaceutical companies in Q2 2023

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

The benefits of using a nimble platform from phase to phase

The benefits of using a nimble platform from phase to p...

Oct 6, 2024

Subcutaneous drugs grant a new lease on life to checkpoint inhibitors

Subcutaneous drugs grant a new lease on life to checkpo...

Sep 9, 2023

Analytical testing: Ten questions that accelerate drug development

Analytical testing: Ten questions that accelerate drug ...

Nov 14, 2023